Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Shay Weiss and Shmuel Yitzhaki.
Shay Weiss
Connection Strength
0.570
Shmuel Yitzhaki
  1. Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities. Clin Microbiol Infect. 2020 Dec; 26(12):1658-1662.
    View in: PubMed
    Score: 0.226
  2. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
    View in: PubMed
    Score: 0.060
  3. Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice. iScience. 2021 May 21; 24(5):102479.
    View in: PubMed
    Score: 0.059
  4. A single dose of recombinant VSV-?G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun. 2020 12 16; 11(1):6402.
    View in: PubMed
    Score: 0.057
  5. A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes. Nat Commun. 2020 08 27; 11(1):4303.
    View in: PubMed
    Score: 0.056
  6. Evaluating the efficacy of RT-qPCR SARS-CoV-2 direct approaches in comparison to RNA extraction. Int J Infect Dis. 2020 Oct; 99:352-354.
    View in: PubMed
    Score: 0.056
  7. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel. Microbiol Resour Announc. 2020 Jul 09; 9(28).
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.